FibroBiologics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $0.73-$14.39 |
Market Cap | $4.4M |
Shares Short | 135,794 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$6.96 |
News
See moreYahoo Finance • 16 days ago
FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
Yahoo Finance • 24 days ago
FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing
Yahoo Finance • last month
Is FibroBiologics, Inc. (FBLG) Advancing Toward a Breakthrough Psoriasis Treatment With CYPS317 Data?
Yahoo Finance • 2 months ago
FibroBiologics Advancing Development of a Fibroblast Treatment for Hantavirus
About
CEO | Mr. Peter O'Heeron |
Address | 455 East Medical Center Boulevard, Houston, TX, United States, 77598 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 15 |